Activity and structure relationship of acridine derivatives against African trypanosomes. 1995

W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
Swiss Tropical Institute, Basel.

48 newly synthesized acridine derivatives of different classes were screened for antitrypanosomal activity. They showed a dose dependent effect on Trypanosoma rhodesiense and T. brucei bloodstream forms measured by the inhibition of esterase activity in a fluorescence based in vitro assay. After analysis of the IC50 and MIC values of the investigated acridines it was obvious that no new compound reached the level of the trypanocidal drugs in use (50 ng/ml). Most of the derivatives had IC50 values in the range of 1 to 10 micrograms/ml. 9 derivatives from different classes of acridines were in vitro active below 1 microgram/ml. Correlations between structure and effect on trypanosomes have been elucidated by comparing the IC50 and MIC values of these compounds, in the course of which no significant differences in the drug susceptibility between T. brucei und T. rhodesiense was noticed. The dialkylaminoalkyl derivatives among the group of the 9-thioacridines were slightly more potent than the mono-alkylated ones. 1,2,3,4-tetrahydro-9-thioacridines showed the influence of higher substituted side chains on the trypanocidal activity in the same way as 9-thioacridines. The corresponding ketones of 9-thioacridines confirmed the tendency of increasing toxicity due to the derivatisation of the dialkylaminoalkyl side chain. Within the series of the 9-aminoacridines the elongation of the side chain did not markedly change the activity, however the IC50 values are generally low between 0.13 and 1.2 micrograms/ml.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D000166 Acridines Compounds that include the structure of acridine. Acridine
D000609 Aminoacridines Acridines which are substituted in any position by one or more amino groups or substituted amino groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014346 Trypanosoma brucei brucei A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina). Trypanosoma brucei,Trypanosoma brucei bruceus,Trypanosoma bruceus,brucei brucei, Trypanosoma,brucei, Trypanosoma brucei,bruceus, Trypanosoma,bruceus, Trypanosoma brucei
D016833 Trypanosoma brucei rhodesiense A hemoflagellate subspecies of parasitic protozoa that causes Rhodesian sleeping sickness in humans. It is carried by Glossina pallidipes, G. morsitans and occasionally other species of game-attacking tsetse flies. Trypanosoma rhodesiense,Trypanosoma brucei rhodesienses,Trypanosoma rhodesienses,brucei rhodesiense, Trypanosoma,brucei rhodesienses, Trypanosoma,rhodesienses, Trypanosoma,rhodesienses, Trypanosoma brucei

Related Publications

W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
November 2018, Antimicrobial agents and chemotherapy,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
January 2009, Antimicrobial agents and chemotherapy,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
April 2011, Biochimica et biophysica acta,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
February 1979, Antimicrobial agents and chemotherapy,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
March 2012, Journal of medicinal chemistry,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
January 2013, Current medicinal chemistry,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
January 2000, Acta poloniae pharmaceutica,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
January 2000, Acta poloniae pharmaceutica,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
January 1977, Nature,
W Obexer, and C Schmid, and J Barbe, and J P Galy, and R Brun
October 2009, Current opinion in immunology,
Copied contents to your clipboard!